Biocon, Mylan get USFDA approval for insulin glargine injection Semglee Ruchika Sharma12 Jun 2020 1:17 PM ISTSemglee has an identical amino acid sequence to Sanofi's Lantus® and is approved for the same indications
Lupin, Mylan get European nod to market Nepexto for treating arthritis, psoriasis Ruchika Sharma5 Jun 2020 12:08 PM ISTMumbai: Lupin Limited and Mylan N.V. have announced that the European Commission (EC) has granted marketing authorization for Nepexto®, a biosimilar...
Mylan, Revance to Advance Development Program for Biosimilar to BOTOX Ruchika Sharma5 Jun 2020 9:00 AM ISTMylan and Revance signed a collaboration and license agreement in February 2018 for the development and regulatory approval of a biosimilar to BOTOX,...
NPPA fixes retail price of 40 Formulations; Details Farhat Nasim2 Jun 2020 4:58 PM ISTThe formulations mentioned in the list are combination drugs such as Voglibose + Metformin Tablet; Ramipril + Metoprolol Tablet; Atorvastatin +...
Insulin Device Patent Row: Biocon, Mylan Get Favourable Ruling from US Patent Board Ruchika Sharma1 Jun 2020 5:03 PM ISTBengaluru: Biocon Ltd. has announced that the U.S. Patent and Trademark Appeal Board (PTAB) has ruled in favor of Mylan, Biocon's partner in inter...
Mylan partner AGP to sell COVID-19 drug Remdesivir soon: Bloomberg Ruchika Sharma1 Jun 2020 10:00 AM ISTIt has a similar arrangement for the Hepatitis C treatment Sovaldi, which will import from Mylan
COVID Antibody: Zydus Cadila gets nod for ICMR-NIV developed ELISA kit Ruchika Sharma16 May 2020 1:35 PM ISTNew Delhi: In a major breakthrough, drugmaker Zydus Cadila has received validation from the National Institute of Virology (NIV), Pune for...
Mylan Releases "A Legacy of Impact: 2019 Global Social Responsibility Report" Ruchika Sharma10 May 2020 9:30 AM ISTHertfordshire, Pittsburgh: Drug major Mylan has released a Comprehensive report focusing on its legacy impact and including a look at Mylan's...
Biocon, Mylan Launch Fulphila, Biosimilar Pegfilgrastim in Canada Ruchika Sharma29 April 2020 2:35 PM ISTBengaluru: Biocon Ltd. and Mylan N.V. have announced the launch of Fulphila®, a biosimilar to Neulasta® (pegfilgrastim).Fulphila is approved by Health...
Biocon, Mylan Launch Fulphila, Biosimilar Pegfilgrastim in Australia Medical Dialogues Bureau15 April 2020 1:30 PM ISTBengaluru, Hertfordshire, Pittsburgh: Biocon Ltd. and Mylan N.V. have announced the launch of Fulphila®, a biosimilar to Neulasta® (pegfilgrastim) in...
Mylan acquires certain businesses from Famy Care Pooja Bhatia Bhatia21 Nov 2015 9:58 AM ISTMumbai, Nov 20 : Pharma major Mylan today said its subsidiary Mylan Laboratories has completed acquisition of Famy Care to create a leading women's...
HC allows DCGI to process Reliance's package insert of cancer Pooja Bhatia Bhatia20 Nov 2015 9:45 AM ISTNew Delhi : Delhi High Court today told the Drug Controller General of India (DCGI) that it can process the application of Reliance Life Sciences for...
